Has Meredith Gershon, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,573 in general payments to Meredith Gershon, MD across 51 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Meredith Gershon, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Meredith Gershon, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Meredith Gershon, MD

Ophthalmology · Trumbull, CTNPI 1699746339

Payments from drug & device makers

$1,573in general payments, 2019–2025

Across 51 payments — averaging $30.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Regeneron Healthcare Solutions, Inc.$482
Genentech USA, Inc.$330
Apellis Pharmaceuticals, Inc.$177
Coherus Oncology, Inc.$169
Astellas Pharma US Inc$144
AbbVie$136
plus $134 from 4 others

What the payments were for

Food & beverage$1,573100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Regeneron Healthcare Solutions, Inc.	14	$482
Genentech USA, Inc.	14	$330
Apellis Pharmaceuticals, Inc.	3	$177
Coherus Oncology, Inc.	2	$169
Astellas Pharma US Inc	6	$144
AbbVie	6	$136
Eyepoint US, Inc.	2	$46
Alimera Sciences, Inc.	2	$38
Mallinckrodt Hospital Products Inc.	1	$28
Sun Pharmaceutical Industries Inc.	1	$22

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Cimerli$128
EYLEA$120

How this compares

$1,573 in reported general payments places this provider in the 60th percentile of 279 ophthalmology providers in Connecticut.

See all ophthalmology providers in Connecticut →

Medicare billing

Part B allowed, 2024

$1,070,666

Medicare patients

270

Services billed

10,176

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Prednisolone Acetate	37	$1,717
Bromfenac Sodium	12	$1,280
Tobramycin-DexamethasoneTobramycin/Dexamethasone	13	$594
Brimonidine Tartrate	13	$380
Latanoprost	20	$370
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat	12	$77

Paid to pharmacies, not to this prescriber.

Other ophthalmology in Trumbull

Matthew PaulDanbury$944K
Amir CohenNew Haven$441K
John HuangHartford$390K
James MurphyHamden$176K
Anthony DanielsNew Haven$66K
James TalbotNew Canaan$47K
Paul KangNew Haven$40K
Anish ShahNorwich$38K
Alan SolinskyWest Hartford$35K
Michael KovalFarmington$35K

See the full list for Connecticut →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →